WATERS CORP /DE/(WAT)— Stock Profile, AI Score & Financials

Technology · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

WATERS CORP /DE/ (WAT) stock profile, AI quality score, and SEC EDGAR financial data, a Technology sector company. 13F Pro's AI-powered ranking engine scores WAT at 60.4/100 on a 32-signal composite quality model, placing it at rank #853 of 2,960 stocks — the top half of the AI-ranked universe. WAT scores in the top quartile across revenue growth (85.8), earnings quality (82.2), revenue scale (76.9). Areas of concern include profitability (31.7), which score below median versus the broader universe. Shareholder dilution risk is elevated at 43.0/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), WATERS CORP /DE/ reports quarterly revenue of $1.6B, net income of $-136.0M, free cash flow of $153.0M. Top institutional holders of WAT by reported 13-F value include BlackRock, MASSACHUSETTS FINANCIAL SERVICES, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. WAT trades on the NYSE exchange and files with the SEC under CIK 1000697. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate WAT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for WATERS CORP /DE/ directly from SEC EDGAR.

AI Quality Score

60.4/100

AI Rank

#853

Revenue

$1.6B

Net Income

$-136.0M

Free Cash Flow

$153.0M

WAT key financials by period

WATERS CORP /DE/ reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202510-K$3.2B$642.6M25.4%
FY 202410-K$3.0B$637.8M27.9%
FY 202310-K$3.0B$642.2M27.7%
FY 202210-K$3.0B$707.8M29.4%
FY 202110-K$2.8B$692.8M29.5%
FY 202010-K$2.4B27.3%

Institutions holding WAT

Institutional investors reporting a position in WATERS CORP /DE/ on SEC Form 13F.
InstitutionSharesValueReported
BlackRock8,484,939$3.2B2026-06-30
MASSACHUSETTS FINANCIAL SERVICES4,625,035$2.5B2026-06-30
VANGUARD CAPITAL MANAGEMENT6,415,552$2.4B2026-06-30
VANGUARD PORTFOLIO MANAGEMENT4,740,524$1.8B2026-06-30
STATE STREET4,382,008$1.6B2026-06-30
T. Rowe Price Investment Management3,817,779$1.4B2026-06-30
Invesco Ltd.3,494,267$1.3B2026-06-30
GEODE CAPITAL MANAGEMENT2,636,146$984.8M2026-06-30
Fundsmith LLP2,273,632$852.7M2026-06-30
PRICE T ROWE ASSOCIATES2,177,958$816.8M2026-06-30
WAT

WATERS CORP /DE/

WAT
NYSELarge CapTechnology

13F Pro Quality Score

60.4/100

Rank #853 of 2,960 stocksTOP 50%

View Technology peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

85.8/100

Profitability

31.7/100

Balance Sheet

44.6/100

Earnings Quality

82.2/100

Free Cash Flow

53.1/100

Institutional Flow

75.5/100

Revenue Scale

76.9/100

Dilution Risk

43.0/100

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

What's Driving WAT's Business? Latest 10-Q Breakdown

37/37 datapoints verified

AI-extracted from the 10-Q filed 2026-08-11 — Q2 FY2026 (quarter ended July 4, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Revenue more than doubled to $1,645M (+113% YoY) on the $13B BDS Business acquisition, but purchased intangibles amortization, inventory step-up and integration costs pushed the company to an operating loss of $86M versus $188M of operating income a year ago.

Biggest Revenue Drivers

Analytical & Materials Sciences$756M+7% YoY

Broad-based growth led by higher demand for Acquity and Xevo TQ-S instrument systems and double-digit chemistry consumables growth

Advanced Diagnostics$521Mvs $62M prior year (not meaningful)

Includes $72M from the recast Waters Clinical business; remainder is BDS Business revenue since the February 9, 2026 acquisition close

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Key Metrics

Revenue

Q2 2026
EDGAR

$1.65B

Net Income

Q2 2026
EDGAR

$-136.00M

EPS (Diluted)

Q2 2026
EDGAR

$-1.39

ROIC

Q2 2026
EDGAR

-1.7%

Free Cash Flow

Q2 2026
EDGAR

$153.00M

Debt/Equity

Q2 2026
EDGAR

0.32

Top Institutional Holders

as of Q2 2026
$37.48B total

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…